“…An abnormal composition and release of arachidonic acid and other free fatty acids has been reported in disorders in the CNS including cerebral ischemia (Edgar et al, 1982;Rordorf et al, 1991;Clemens et al, 1996), traumatic brain injury (Shohami et al, 1989), schizophrenia (Ross et al, 1997), and seizures (Bazan et al, 1982;Siesjo et al, 1982). For this reason, and in view of the presence of numerous inflammatory mediators and acute phase proteins in diseased brain, localization of cPLA 2 was evaluated in several different experimental and clinical conditions of CNS injury.…”